Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

If you're focused on delivering a high return on capital for your shareholders, you should consider M&A as an integral part ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...